GlassScriptPhysician profile
Jianghui Zhang
NPI 1508020751
$10,850.91
in general payments reported to CMS, 2019-2025
16 companies · $608 in 2025
The $608 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $787 · 2020: $65.88 · 2021: $83.00 · 2022: $282 · 2023: $2,047 · 2024: $6,978 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,182 · Food and Beverage: $4,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,182.49 |
| Food and Beverage | $4,450.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $5,525.44 | 2024-2025 | Perla Tl Mis, Bone Substitute, Scarlet Al-T |
| Spineology INC. | $1,768.14 | 2024 | Optimesh Expandable Interbody Fusion System |
| Orthofix Medical, INC. | $1,667.10 | 2023 | Waveform L, Regatta Lateral System |
| Si-Bone, INC. | $539.54 | 2019-2023 | |
| Amgen INC. | $282.79 | 2020-2022 | |
| Stryker Corporation | $278.78 | 2020-2024 | Omnicurve, Spinejack |
| Medical Device Business Services, INC. | $205.10 | 2019 | |
| Uoc USA INC | $149.21 | 2023 | U2, Conformity, U-Motion II and Ustar II |
| Gilead Sciences, INC. | $109.58 | 2019 | |
| Janssen Pharmaceuticals, INC | $72.00 | 2019 | |
| Depuy Synthes Sales INC. | $66.61 | 2024 | Monovisc, Orthovisc |
| Arbor Pharmaceuticals, INC. | $55.31 | 2021 | |
| Heron Therapeutics, INC. | $53.00 | 2023 | Zynrelef |
| Globus Medical, INC. | $29.95 | 2023 | Ankle Fracture System |
| Vertex Pharmaceuticals Incorporated | $26.53 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $21.83 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jianghui Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.